-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
6-Acetylpyridine-2-carboxylic acid ethyl ester, also known as APC-242, is a chemical compound that has been widely used in the industrial and pharmaceutical sectors.
This compound is known for its ability to act as a potent and selective antagonist of the cannabinoid receptor type 2 (CB2).
APC-242 is commonly used in research studies to investigate the potential therapeutic benefits of cannabinoids for a variety of medical conditions, including pain, inflammation, and anxiety.
However, in recent years, there has been growing concern about the safety of APC-242, particularly in terms of its potential to cause adverse side effects.
In this article, we will examine the current information available on the safety of APC-242, including its potential toxicity, as well as any precautions that should be taken when handling this compound.
Toxicity of APC-242
APC-242 is known to have a relatively high degree of potency as an antagonist of the CB2 receptor, and it is therefore important to be cautious when handling this compound.
Despite this, there is limited information available on the toxicity of APC-242 in humans.
However, animal studies have shown that APC-242 can produce adverse side effects at high doses.
For example, a study published in the Journal of Pharmacology and Experimental Therapeutics found that APC-242 produced dose-dependent decreases in body weight and food consumption in rats, along with other signs of toxicity.
Other studies have also shown that APC-242 can produce a range of adverse effects on the respiratory, cardiovascular, and central nervous systems of animals.
For example, a study published in the European Journal of Pharmacology found that APC-242 produced dose-dependent decreases in lung function in rats, while another study published in the British Journal of Pharmacology found that APC-242 produced dose-dependent decreases in blood pressure in hypertensive rats.
Precautions for handling APC-242
Given the potential toxicity of APC-242, it is important to take precautions when handling this compound.
If you are working with APC-242 in a laboratory or research setting, it is important to wear appropriate protective gear, including gloves, goggles, and a laboratory coat.
Additionally, you should avoid touching your face or eyes while working with APC-242.
It is also important to ensure that you are familiar with the proper handling and storage procedures for APC-242, as well as any relevant safety data sheets (SDS).
If you are unsure about how to handle or store APC-242, it is recommended that you seek the advice of a qualified professional.
Conclusion
APC-242 is a compound with demonstrated potency as an antagonist of the CB2 receptor for cannabinoids, and it has been widely used in research studies to investigate the potential therapeutic benefits of cannabinoids for a range of medical conditions.
While there is limited information available on the toxicity of APC-242 in humans, animal studies have shown that it can produce adverse side effects at high doses.
It is important to take precautions when handling APC-242, including wearing appropriate protective gear and following proper handling and storage procedures.
If you are unsure about how to handle or store APC-242, it is recommended that you seek the advice of a qualified professional.